It's true that Mistral AI securing such a significant fundraising round offers a compelling argument for investor confidence in high-value AI ventures operating under the EU AI Act.
One could easily argue this success provides valuable informational context by demonstrating that substantial investment is possible within the current regulatory framework.
However, to suggest this singular event is almost a necessary condition for assessing the overall viability of the AI Act for the broader market might be overlooking the diverse landscape of AI development.
A single, well-capitalized company's success doesn't automatically mean the compliance costs or legal uncertainties won't present significant hurdles for smaller startups or those with less access to capital, much like a successful operation on one patient doesn't mean the whole hospital system is equally accessible for everyone.
We need to look beyond the headlines to the everyday practicalities for all players, not just the unicorns.